Literature DB >> 9577289

Long-term gastric pH monitoring for determining optimal dose of ranitidine for critically ill preterm and term neonates.

A L Kuusela1.   

Abstract

AIM: To determine the optimal doses of ranitidine for both preterm and term infants.
METHOD: The effect of ranitidine treatment was measured from the long-term intraluminal gastric pH in 16 preterm (gestational age under 37 weeks) and term infants treated in neonatal intensive care. The infants received three different bolus doses of ranitidine: 0.5 mg, 1.0 mg, and 1.5 mg per kilogram of body weight to keep the intraluminal gastric pH above 4 on a 24 hour basis.
RESULTS: Critically ill neonates, including very low birth weight infants, were capable of gastric acid formation, and ranitidine treatment increased the intraluminal gastric pH. The effect of a single dose lasted longer in preterm than in term infants. The time needed for reaching the maximum gastric pH was significantly longer in preterm than in term infants. The ranitidine given correlated with the duration of increased gastric pH in a dose dependent manner both in preterm and term infants.
CONCLUSION: Preterm infants need significantly smaller doses of ranitidine than term neonates to keep their intraluminal gastric pH over 4. The required optimal dose of ranitidine for preterm infants is 0.5 mg/kg/body weight twice a day and that for term infants 1.5 mg/kg body weight three times a day.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9577289      PMCID: PMC1720764          DOI: 10.1136/fn.78.2.f151

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  20 in total

Review 1.  Gastric mucosal acid-base balance.

Authors:  E Kivilaakso; T Kiviluoto; H Mustonen; H Paimela
Journal:  J Intern Med Suppl       Date:  1990

2.  Pharmacokinetics of ranitidine in critically ill infants.

Authors:  D B Wiest; W O'Neal; J R Reigart; R C Brundage; P C Gillette; R L Yost
Journal:  Dev Pharmacol Ther       Date:  1989

Review 3.  Mechanisms of stress-related mucosal damage.

Authors:  T A Miller
Journal:  Am J Med       Date:  1987-12-18       Impact factor: 4.965

4.  Gastric acidity in the first day of life.

Authors:  G B Avery; J G Randolph; T Weaver
Journal:  Pediatrics       Date:  1966-06       Impact factor: 7.124

5.  Use of H2-receptor antagonists in children.

Authors:  R J Dimand
Journal:  DICP       Date:  1990-11

6.  Prophylactic therapy for stress ulcer bleeding: a reappraisal.

Authors:  R B Shuman; D P Schuster; G R Zuckerman
Journal:  Ann Intern Med       Date:  1987-04       Impact factor: 25.391

Review 7.  Do H2 receptor antagonists have a therapeutic role in childhood?

Authors:  D A Kelly
Journal:  J Pediatr Gastroenterol Nutr       Date:  1994-10       Impact factor: 2.839

Review 8.  Stress ulcer prophylaxis in medical patients: who, what, and how much?

Authors:  C M Wilcox; J G Spenney
Journal:  Am J Gastroenterol       Date:  1988-11       Impact factor: 10.864

9.  Bolus or intravenous infusion of ranitidine: effects on gastric pH and acid secretion. A comparison of relative efficacy and cost.

Authors:  M A Ballesteros; D L Hogan; M A Koss; J I Isenberg
Journal:  Ann Intern Med       Date:  1990-03-01       Impact factor: 25.391

10.  Continuous gastric pH measurement in young and older healthy preterm infants receiving formula and clear liquid feedings.

Authors:  J M Sondheimer; D A Clark; E P Gervaise
Journal:  J Pediatr Gastroenterol Nutr       Date:  1985-06       Impact factor: 2.839

View more
  7 in total

1.  Risk management, or just a different risk?

Authors:  Y Freer; A Lyon
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-02-07       Impact factor: 5.747

2.  Pharmacological interventions for prevention and treatment of upper gastrointestinal bleeding in newborn infants.

Authors:  Daniel Stephen Green; Mohamed E Abdel-Latif; Lisa J Jones; Kei Lui; David A Osborn
Journal:  Cochrane Database Syst Rev       Date:  2019-07-02

Review 3.  Gastroesophageal reflux disease in neonates and infants : when and how to treat.

Authors:  Steven J Czinn; Samra Blanchard
Journal:  Paediatr Drugs       Date:  2013-02       Impact factor: 3.022

4.  Acid reducing agents to neonates - lack of evidence and guidelines.

Authors:  Stina Paulsson; Staffan Eksborg; Åsa Andersson; Per Nydert; Lena Grahnquist
Journal:  J Drug Assess       Date:  2012-01-09

5.  Pharmacokinetics of ranitidine in preterm and term neonates with gastroesophageal reflux.

Authors:  Ismael Lares Asseff; Graciela Benitez Gaucin; Hugo Juárez Olguín; Jose Antonio Godinez Nájera; Alejandra Toledo López; Gabriela Pérez Guillé; Fausto Zamura Torres
Journal:  BMC Pediatr       Date:  2016-07-13       Impact factor: 2.125

Review 6.  Interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care units.

Authors:  Ingrid Toews; Aneesh Thomas George; John V Peter; Richard Kirubakaran; Luís Eduardo S Fontes; Jabez Paul Barnabas Ezekiel; Joerg J Meerpohl
Journal:  Cochrane Database Syst Rev       Date:  2018-06-04

7.  Pharmacological therapy of gastroesophageal reflux in preterm infants.

Authors:  Luigi Corvaglia; Caterina Monari; Silvia Martini; Arianna Aceti; Giacomo Faldella
Journal:  Gastroenterol Res Pract       Date:  2013-06-26       Impact factor: 2.260

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.